Fresenius Purchase of NxStage Delayed Until August by FTC
The government shutdown delayed FTC approval of a Fresenius acquisition of NxStage Medical, Inc. The transaction is now expected to close in August 2019.
Read the full article » | Posted 02-14-2019
Related Articles
- Baxter ASN Presence, 2018 Posted 10-05-2026
- Fresenius Kidney Care Reports PD Breakthroughs Posted 10-05-2026
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026